Concepedia

Jonathan Lucchesi

JL

6

Publications

162

Citations

6

H-Index

2013

Active since

Affiliations

Eli Lilly (United States)(Current)

Jonathan Lucchesi is an author at Eli Lilly (United States) specializing in medicine, bone metabolism, and osteoporosis.

Top concepts

Publications per year

2013–2023

6

Publications

6

Defective enamel and bone development in sodium-dependent citrate transporter (NaCT) Slc13a5 deficient mice

Armando R. Irizarry, Guirui Yan, Qingqiang Zeng et al. · PLoS ONE · 2017 · 49 citations · Full text

, , +16

Inhibition of myostatin prevents microgravity-induced loss of skeletal muscle mass and strength

Rosamund C. Smith, Martin S. Cramer, Pamela J. Mitchell et al. · PLoS ONE · 2020 · 44 citations · Full text

, , +20

Efficacy of a sclerostin antibody compared to a low dose of PTH on metaphyseal bone healing

Fredrik Agholme, Brandon R. Macias, Matt Hamang et al. · Journal of Orthopaedic Research® · 2013 · 23 citations · Full text

Time course of disassociation of bone formation signals with bone mass and bone strength in sclerostin antibody treated ovariectomized rats

Matthew Hamang, Jonathan Lucchesi, Nicoletta Bivi et al. · Bone · 2016 · 22 citations

, , +12

Elevated levels of Interleukin (IL)-33 induce bone pathology but absence of IL-33 does not negatively impact normal bone homeostasis

Angela J. Okragly, Matthew Hamang, Emily A. Pena et al. · Cytokine · 2016 · 12 citations

, , +11

Rows per page

1–5 of 6